We confirmed that CD4+CD25highCD39+ T cells from MS patients in the acute phase of the disease are indeed suppressive, as shown in Fig. 4 D–F, thus suggesting that the T regulatory compartment is not functionally compromised in patients affected by MS. The gene discussed is CD4; the disease is myeloid sarcoma.